Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status
Petra Leidinger(Saarland University), Eckart Meese(Saarland University), Andreas Keller(Helmholtz Institute for Pharmaceutical Research Saarland), Stefanie Rheinheimer(Saarland University), Bastian Keck(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bernd Wullich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Martin Hart(Institute of Human Genetics), Christina Backes(Saarland University)
Cited by 52
Related Papers
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
|Nature Methods|2017|1.3k
Distribution of miRNA expression across human tissues
|Nucleic Acids Research|2016|1k
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
A blood based 12-miRNA signature of Alzheimer disease patients
|Genome biology|2013|514
New insights into the Tyrolean Iceman's origin and phenotype as inferred by whole-genome sequencing
|Nature Communications|2012|464